Overview

A Prospective, Open Label Study of CERtican in KIdney Transplantation

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
A prospective, open label study of CERtican in KIdney transplantation
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Everolimus
Sirolimus